Main content

AstraZeneca vaccine: What impact will the policy change have?

Under-30s in the UKΒ are to be offered an alternative vaccine to the AstraZeneca jabΒ due to the evidence linking it to rare blood clots. But what impact will the policy change have? And could the vaccine rollout suffer?

The recommendation comes after a review by the UK drugs regulator found that by the end of March 79 people had suffered rare blood clots after vaccination - 19 of whom had died.

The regulator said this was not proof the jab had caused the clots.

But it said the link was getting firmer.

Newsnight's Health Correspondent Deb Cohen reports.

MORE: https://bbc.in/2Rh5QBx

Release date:

Duration:

16 minutes